- call +1-201-465-4211
- email sales@mrinsights.biz
Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication concentrations in blood. Its main focus is on drugs with a narrow therapeutic window. TDM aims at improving patient care by adjusting the dose of drugs for which clinical experience or clinical trials have shown it improved outcome in the general or special populations. It can be based on a priori pharmacogenetic, demographic and clinical information, and/or on the a posteriori measurement of blood concentrations of drugs.
Scope of the Report:
This report studies the Therapeutic Drug Monitoring market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Therapeutic Drug Monitoring market by product type and applications/end industries.
In 2018, North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region.
The global Therapeutic Drug Monitoring market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Therapeutic Drug Monitoring.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Roche
Siemens Healthineers
Thermo Fisher
Danaher
Bio-Rad Laboratories
Biomerieux
Buhlmann Laboratories
Sekisui Medical
Randox Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antiepileptic Drugs
Antiarrhythmic Drugs
Immunosuppressant Drugs
Antibiotic Drugs
Bronchodilator Drugs
Psychoactive Drugs
Other Drug Classes
Market Segment by Applications, can be divided into
Commercial/Private Labs
Hospital Labs
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Therapeutic Drug Monitoring Market Overview
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring by Types
1.2.1 Global Therapeutic Drug Monitoring Revenue Comparison by Types (2017-2023)
1.2.2 Global Therapeutic Drug Monitoring Revenue Market Share by Types in 2017
1.2.3 Antiepileptic Drugs
1.2.4 Antiarrhythmic Drugs
1.2.5 Immunosuppressant Drugs
1.2.6 Antibiotic Drugs
1.2.7 Bronchodilator Drugs
1.2.8 Psychoactive Drugs
1.2.9 Other Drug Classes
1.3 Global Therapeutic Drug Monitoring Market by Application
1.3.1 Global Therapeutic Drug Monitoring Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Commercial/Private Labs
1.3.3 Hospital Labs
1.3.4 Others
1.4 Global Therapeutic Drug Monitoring Market by Regions
1.4.1 Global Therapeutic Drug Monitoring Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Therapeutic Drug Monitoring Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Therapeutic Drug Monitoring Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Therapeutic Drug Monitoring Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Therapeutic Drug Monitoring Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Therapeutic Drug Monitoring Status and Prospect (2013-2023)
1.5 Global Market Size of Therapeutic Drug Monitoring (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Therapeutic Drug Monitoring Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Therapeutic Drug Monitoring Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens Healthineers
2.3.1 Business Overview
2.3.2 Therapeutic Drug Monitoring Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Healthineers Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thermo Fisher
2.4.1 Business Overview
2.4.2 Therapeutic Drug Monitoring Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.5 Danaher
2.5.1 Business Overview
2.5.2 Therapeutic Drug Monitoring Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Danaher Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad Laboratories
2.6.1 Business Overview
2.6.2 Therapeutic Drug Monitoring Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.7 Biomerieux
2.7.1 Business Overview
2.7.2 Therapeutic Drug Monitoring Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biomerieux Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.8 Buhlmann Laboratories
2.8.1 Business Overview
2.8.2 Therapeutic Drug Monitoring Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Buhlmann Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sekisui Medical
2.9.1 Business Overview
2.9.2 Therapeutic Drug Monitoring Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sekisui Medical Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.10 Randox Laboratories
2.10.1 Business Overview
2.10.2 Therapeutic Drug Monitoring Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Randox Laboratories Therapeutic Drug Monitoring Revenue, Gross Margin and Market Share (2016-2017)
3 Global Therapeutic Drug Monitoring Market Competition, by Players
3.1 Global Therapeutic Drug Monitoring Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Therapeutic Drug Monitoring Players Market Share
3.2.2 Top 10 Therapeutic Drug Monitoring Players Market Share
3.3 Market Competition Trend
4 Global Therapeutic Drug Monitoring Market Size by Regions
4.1 Global Therapeutic Drug Monitoring Revenue and Market Share by Regions
4.2 North America Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
4.3 Europe Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
4.5 South America Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
5 North America Therapeutic Drug Monitoring Revenue by Countries
5.1 North America Therapeutic Drug Monitoring Revenue by Countries (2013-2018)
5.2 USA Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
5.3 Canada Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
5.4 Mexico Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
6 Europe Therapeutic Drug Monitoring Revenue by Countries
6.1 Europe Therapeutic Drug Monitoring Revenue by Countries (2013-2018)
6.2 Germany Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
6.3 UK Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
6.4 France Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
6.5 Russia Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
6.6 Italy Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Therapeutic Drug Monitoring Revenue by Countries
7.1 Asia-Pacific Therapeutic Drug Monitoring Revenue by Countries (2013-2018)
7.2 China Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
7.3 Japan Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
7.4 Korea Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
7.5 India Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
8 South America Therapeutic Drug Monitoring Revenue by Countries
8.1 South America Therapeutic Drug Monitoring Revenue by Countries (2013-2018)
8.2 Brazil Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
8.3 Argentina Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
8.4 Colombia Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Therapeutic Drug Monitoring by Countries
9.1 Middle East and Africa Therapeutic Drug Monitoring Revenue by Countries (2013-2018)
9.2 Saudi Arabia Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
9.3 UAE Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
9.4 Egypt Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
9.5 Nigeria Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
9.6 South Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2013-2018)
10 Global Therapeutic Drug Monitoring Market Segment by Type
10.1 Global Therapeutic Drug Monitoring Revenue and Market Share by Type (2013-2018)
10.2 Global Therapeutic Drug Monitoring Market Forecast by Type (2018-2023)
10.3 Antiepileptic Drugs Revenue Growth Rate (2013-2023)
10.4 Antiarrhythmic Drugs Revenue Growth Rate (2013-2023)
10.5 Immunosuppressant Drugs Revenue Growth Rate (2013-2023)
10.6 Antibiotic Drugs Revenue Growth Rate (2013-2023)
10.7 Bronchodilator Drugs Revenue Growth Rate (2013-2023)
10.8 Psychoactive Drugs Revenue Growth Rate (2013-2023)
10.9 Other Drug Classes Revenue Growth Rate (2013-2023)
11 Global Therapeutic Drug Monitoring Market Segment by Application
11.1 Global Therapeutic Drug Monitoring Revenue Market Share by Application (2013-2018)
11.2 Therapeutic Drug Monitoring Market Forecast by Application (2018-2023)
11.3 Commercial/Private Labs Revenue Growth (2013-2018)
11.4 Hospital Labs Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Therapeutic Drug Monitoring Market Size Forecast (2018-2023)
12.1 Global Therapeutic Drug Monitoring Market Size Forecast (2018-2023)
12.2 Global Therapeutic Drug Monitoring Market Forecast by Regions (2018-2023)
12.3 North America Therapeutic Drug Monitoring Revenue Market Forecast (2018-2023)
12.4 Europe Therapeutic Drug Monitoring Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Therapeutic Drug Monitoring Revenue Market Forecast (2018-2023)
12.6 South America Therapeutic Drug Monitoring Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Therapeutic Drug Monitoring Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Therapeutic Drug Monitoring Picture
Table Product Specifications of Therapeutic Drug Monitoring
Table Global Therapeutic Drug Monitoring and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
